Open original FDA record ↗Recall record
- FDA identifier
- Z-0108-2020
- Company in FDA record
- Roche Diagnostics Operations, Inc.
- FDA record creation date
- Oct 9, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Tina-quant Soluble Transferrin Receptor (STFR) Assays Updated Claims for Rheumatoid Factors Interference
Source facts
- Action
- Roche issued notification to consignees by Urgent Medical Device Correction (TP-00754) sent via UPS (signature required) on 8/28/19. The UMDC will also be available on diagnostics.roche.com. The letter identifies the problem, risk to health and action to take: Be aware of new interference claims that are listed in this UMDC and that the rhEPO Therapy Monitoring Statement will be removed from the Method Sheets. The UMDC will serve as intermediate labeling until the updated method sheets are available. Complete all sections of the enclosed fax form. Contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336 if you have questions if you have questions
- Initiated
- 2019-08-28
- Root cause
- Under Investigation by firm
- Terminated
- 2020-10-02
- Distribution
- Nationwide
- Recall number
- Z-0108-2020
- Recall status
- Terminated
- CDRH record ID
- 176299
- FDA record created
- 2019-10-09
- Recall event number
- 83758